Dezocine for Prevention of Catheter-related Bladder Discomfort

Catheter Related Bladder Discomfort Clinical Trial

Official title:
Efficacy of Dezocine for the Prevention of Catheter-related Bladder Discomfort

Status Completed

Clinical Trial Summary

This study evaluates the efficacy of dezocine in preventing the catheter-related bladder discomfort (CRBD) in a postanesthesia care unit (PACU).

Clinical Trial Description

Thirty min before the end of the surgery, patients were randomly assigned to one of the two group to receive intravenous dezocine 0.1 mg/kg (Group D, n=48) or flurbiprofen axetil 1 mg/kg (Group F, n=48) . The CRBD was assessed at 0, 1, 2, and 6 h after patient's arrival in the post-anaesthesia care unit. Severity of CRBD was graded as none, mild, moderate and severe. ;

Study Design

Related Conditions & MeSH terms

Catheter Related Bladder Discomfort

Clinical Trial Details

NCT number	NCT03147066
Study type	Interventional
Source	Zhongda Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	September 1, 2017
Completion date	October 30, 2017

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01652183` - Paracetamol for Catheter Related Bladder Discomfort	Phase 4
	Completed	`NCT03513250` - Efﬁcacy of Hyoscine-n-butylbromide in Catheter-related Bladder Discomfort After Elective Cesarean Section.	N/A